UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

The Ligands of Translocator Protein: Design and Biological Properties

Current pharmaceutical design, 2021, Vol.27 (2), p.217

2021

Volltextzugriff (PDF)

Novel Technologies for Dipeptide Drugs Design and their Implantation

Current pharmaceutical design, 2018-01, Vol.24 (26), p.3020

2018

Volltextzugriff (PDF)

The Low Molecular Weight Brain-derived Neurotrophic Factor Mimetics with Antidepressant-like Activity

Current pharmaceutical design, 2019-01, Vol.25 (6), p.729

2019

Volltextzugriff (PDF)

Сhronically Administered BDNF Dipeptide Mimetic GSB-106 Prevents the Depressive-like Behavior and Memory Impairments after Transient Middle Cerebral Artery Occlusion in Rats

Current pharmaceutical design, 2023, Vol.29 (2), p.126

2023

Volltextzugriff (PDF)

Analysis of Antidepressant-like Effects and Action Mechanisms of GSB-106, a Small Molecule, Affecting the TrkB Signaling

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13381

2021

Volltextzugriff (PDF)

The New Dipeptide TSPO Ligands: Design, Synthesis and Structure-Anxiolytic Activity Relationship

Molecules (Basel, Switzerland), 2020-11, Vol.25 (21), p.5132

2020

Volltextzugriff (PDF)

Neuroregenerative Activity of the Dipeptide Mimetic of Brain-derived Neurotrophic Factor GSB-106 Under Experimental Ischemic Stroke

CNS & neurological disorders drug targets, 2021, Vol.20 (10), p.954

2021

Volltextzugriff (PDF)

Antidepressant-like Effects of BDNF and NGF Individual Loop Dipeptide Mimetics Depend on the Signal Transmission Patterns Associated with Trk

Pharmaceuticals (Basel, Switzerland), 2022-02, Vol.15 (3), p.284

2022

Volltextzugriff (PDF)

Low-Molecular Weight BDNF Mimetic, Dimeric Dipeptide GSB-106, Reverses Depressive Symptoms in Mouse Chronic Social Defeat Stress

Biomolecules (Basel, Switzerland), 2021-02, Vol.11 (2), p.252

2021

Volltextzugriff (PDF)

Low‐molecular mimetics of nerve growth factor and brain‐derived neurotrophic factor: Design and pharmacological properties

Medicinal research reviews, 2021-09, Vol.41 (5), p.2746-2774

2021

Volltextzugriff (PDF)

Low molecular weight NGF mimetic GK‐2 normalizes the parameters of glucose and lipid metabolism and exhibits a hepatoprotective effect on a prediabetes model in obese Wistar rats

Clinical and experimental pharmacology & physiology, 2022-10, Vol.49 (10), p.1116-1125

2022

Volltextzugriff (PDF)

Design, Synthesis and Anticonvulsant Activity of Cinnamoyl Derivatives of 3,4,6,7,8,9-hexahydrodibenzo[ b,d ]furan-1-(2H)-one Oxime

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2024, Vol.20 (1), p.92

2024

Volltextzugriff (PDF)

Role of the interfaces and the charge of a molecule in the non-equilibrium crystallization of dipeptide nanomaterials onto solid substrates

CrystEngComm, 2018, Vol.2 (47), p.7688-7699

2018

Volltextzugriff (PDF)

Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation

Journal of biomedical science, 2014-08, Vol.21 (1), p.74-74, Article 74

2014

Volltextzugriff (PDF)

GVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons

International journal of developmental neuroscience, 2003-05, Vol.21 (3), p.117-124

2003

Volltextzugriff (PDF)

Design and synthesis of a novel dipeptide mimetic of the 4th loop of neurotrophin-3 and its pharmacological effects

Mendeleev communications, 2023-11, Vol.33 (6), p.786-789

2023

Volltextzugriff (PDF)

A Low-Molecular-Weight BDNF Mimetic, Dipeptide GSB-214, Prevents Memory Impairment in Rat Models of Alzheimer’s Disease

Actanaturae (Russian edition), 2022-10, Vol.14 (4), p.94-100

2022

Volltextzugriff (PDF)

Design of N-Acylprolyltyrosine “Tripeptoid” Analogues of Neurotensin as Potential Atypical Antipsychotic Agents

Journal of medicinal chemistry, 1998-01, Vol.41 (3), p.284-290

1998

Volltextzugriff (PDF)

Design, Synthesis and Pharmacological Activity of New Pyrrolo[1,2-A] Pyrazine Translocator Protein (TSPO) Ligands

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2022-01, Vol.18 (4), p.497

2022

Volltextzugriff (PDF)

Dimeric NGF Mimetic Attenuates Hyperglycaemia and DNA Damage in Mice with Streptozotocin-Induced Early-Stage Diabetes

Endocrine, metabolic & immune disorders drug targets, 2020, Vol.20 (3), p.453

2020

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Animals
(10)
Pharmacology & Pharmacy
(9)
Bdnf
(6)
Dipeptides - Pharmacology
(6)
Male
(6)
Antidepressants
(5)
Brain-Derived Neurotrophic Factor
(5)
Chemistry, Medicinal
(5)
Mice
(5)
Humans
(4)
Molecular Weight
(4)
Peptides
(4)
Rats
(4)
Brain-Derived Neurotrophic Factor - Metabolism
(3)
Chemistry
(3)
Chemistry, Multidisciplinary
(3)
Cholesterol
(3)
Dipeptides - Chemistry
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Ligands of Translocator Protein: Design and Biological Properties

Novel Technologies for Dipeptide Drugs Design and their Implantation

The Low Molecular Weight Brain-derived Neurotrophic Factor Mimetics with Antidepressant-like Activity

Сhronically Administered BDNF Dipeptide Mimetic GSB-106 Prevents the Depressive-like Behavior and Memory Impairments after Transient Middle Cerebral Artery Occlusion in Rats

Analysis of Antidepressant-like Effects and Action Mechanisms of GSB-106, a Small Molecule, Affecting the TrkB Signaling

The New Dipeptide TSPO Ligands: Design, Synthesis and Structure-Anxiolytic Activity Relationship

Neuroregenerative Activity of the Dipeptide Mimetic of Brain-derived Neurotrophic Factor GSB-106 Under Experimental Ischemic Stroke

Antidepressant-like Effects of BDNF and NGF Individual Loop Dipeptide Mimetics Depend on the Signal Transmission Patterns Associated with Trk

Low-Molecular Weight BDNF Mimetic, Dimeric Dipeptide GSB-106, Reverses Depressive Symptoms in Mouse Chronic Social Defeat Stress

Low‐molecular mimetics of nerve growth factor and brain‐derived neurotrophic factor: Design and pharmacological properties

Low molecular weight NGF mimetic GK‐2 normalizes the parameters of glucose and lipid metabolism and exhibits a hepatoprotective effect on a prediabetes model in obese Wistar rats

Design, Synthesis and Anticonvulsant Activity of Cinnamoyl Derivatives of 3,4,6,7,8,9-hexahydrodibenzo[ b,d ]furan-1-(2H)-one Oxime

Role of the interfaces and the charge of a molecule in the non-equilibrium crystallization of dipeptide nanomaterials onto solid substrates

Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation

GVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons

Design and synthesis of a novel dipeptide mimetic of the 4th loop of neurotrophin-3 and its pharmacological effects

A Low-Molecular-Weight BDNF Mimetic, Dipeptide GSB-214, Prevents Memory Impairment in Rat Models of Alzheimer’s Disease

Design of N-Acylprolyltyrosine “Tripeptoid” Analogues of Neurotensin as Potential Atypical Antipsychotic Agents

Design, Synthesis and Pharmacological Activity of New Pyrrolo[1,2-A] Pyrazine Translocator Protein (TSPO) Ligands

Dimeric NGF Mimetic Attenuates Hyperglycaemia and DNA Damage in Mice with Streptozotocin-Induced Early-Stage Diabetes

Suchergebnisse filtern